Ipratropium Bromide

Effects of ipratropium bromide on bronchodilation in patients with asthma and COPD

溴化异丙托品对哮喘和COPD的支气管扩张作用

There were no significant change of adrenoreceptor density after ipratropium bromide and theophylline therapy .

溴化异丙托品组和茶碱组治疗前后β受体密度变化不显著。

Combined Application of Salbutamol and Ipratropium Bromide in the Treatment of Bronchial Asthma in Children

沙丁胺醇联合异丙托溴铵治疗小儿哮喘55例

Combined Salbutamol and Ipratropium Bromide by inhalation in the Treatment of Child Asthma

溴化异丙托品联合沙丁胺醇雾化治疗儿童哮喘

Ipratropium bromide and salbutamol reversed the effect of asthma on BK Ca channel .

异丙托溴铵或沙丁胺醇对哮喘BKCa通道的增强作用主要表现为延长通道开放时间常数，缩短关闭时间常数。

Observation on clinically curative effects of salbutamol and ipratropium bromide on immediate remission of asthma

沙丁胺醇与溴化异丙托品即刻平喘的临床辨证疗效观察

Ipratropium Bromide in the Treatment of Allergic Rhinitis

异丙托溴胺气雾剂在变应性鼻炎治疗中的作用

Compound ipratropium bromide solution for inhalation with combination of corticosteroids effects in acute exacerbations of chronic obstructive pulmonary disease

可必特联合糖皮质激素治疗慢性阻塞性肺病急性加重期疗效分析

To observe the efficacy of budesonide . salbutamol and ipratropium bromide treat bronchiolitis

布地奈德、沙丁胺醇加异丙托溴铵佐治毛细支气管炎疗效观察

Nebulizations of terbutaline plus ipratropium bromide for acute exacerbations of chronic obstructive pulmonary disease

特布他林、异丙托溴铵联合雾化吸入对慢性阻塞性肺病急性加重期的疗效观察

Fenoterol and ipratropium bromide inhalation alone or combined in treatment of childhood acute paroxysm of asthma

非诺特罗及异丙托溴铵单用或联用吸入治疗小儿哮喘发作

Purpose : to observe the effect of combined inhalation therapy of Salbutamol and Ipratropium Bromide on children with acute asthma episode .

目的：观察舒喘灵、溴化异丙托品联合吸入在儿童哮喘急性发作治疗中的疗效。

Objective To investigate the effect of ipratropium bromide and atropine on airway mucin hypersecretion in the chronic bronchitis model of rats .

目的探讨毒蕈碱乙酰胆碱能受体拮抗剂溴化异丙托品及阿托品对气道粘蛋白高分泌的作用。

Conclusion : Atomization inhalation with ipratropium bromide or salbutamol is more effective than aminophylline in treatment of asthmatic diseases in children .

结论：爱喘乐、喘乐宁雾化吸入治疗小儿喘息性疾病有显著疗效。

ObjectiveTo investigate the effect of the oxygen-driven ipratropium bromide nebulization with mask oxygen inhalation devices in patients with conscious disturbance .

目的研究氧气雾化吸入器面罩吸入异丙托溴铵的有效性。

The average recoveries of ipratropium bromide and benzalkonium chloride were 102.0 % and 98.6 % respectively . The method is accurate and simple .

方法灵敏、简便、重现性好，平均回收率分别为102.0%和98.6%。

To compare consistency of 200 μ g albuterol and 80 μ g Ipratropium Bromide as bronchodilator in pulmonary function test in COPD patients .

目的：比较慢性阻塞性肺疾病（COPD）患者吸入200μg沙丁胺醇与吸入80μg溴化异丙托品进行支气管舒张试验结果的一致性。

Significant decrease in the number of tracheal epithelia goblet cells , secretion of mucin were observed in ipratropium bromide and atropine treated rats .

溴化异丙托品和阿托品都显著减少气管上皮杯状细胞数目及粘蛋白的分泌。

MethodsCompared the treatment of the oxygen-driven ipratropium bromide nebulization with mask oxygen inhalation devices and traditional oxygen with nasal catheter .

方法氧气雾化吸入器面罩吸入异丙托溴铵与传统鼻塞吸氧方法进行比较。

The inhibitory effect of ipratropium bromide with salbutamol on the contraction of guinea pig tracheal strips induced by histamine and KCl .

溴化异丙托品和沙丁胺醇合用对组胺、乙酰胆碱和KCl诱导的豚鼠气管条收缩的影响。

Objective To investigate the effective and safety of nebulized budesonide suspension plus Albuterol and ipratropium bromide inhaled in treatment of attack of asthma in children .

目的评价布地奈德雾化悬浊液联合复方异丙托溴铵溶液治疗儿童哮喘急性发作的临床疗效。

Objective To observe the effect of inhaled ipratropium bromide on airway and lung tissue muscarinic receptors ( MR ) in a rat model of chronic obstructive pulmonary disease ( COPD ) .

目的观察吸入溴化异丙托品对大鼠慢性阻塞性肺疾病（COPD）模型气道和肺组织M受体的影响及其规律。

After β 2 agonist and β 2 agonist combine with ipratropium bromide therapy , the adrenoreceptor density were significantly lower than before ( P < 0.01 ) .

沙丁胺醇组和联合用药组治疗后β受体密度较治疗前下降显著（P<0.01）。

Conclusion : The adrenoreceptor will be down regulated after long β 2 agonist therapy . There were no changes of adrenoreceptor after ipratropium bromide and theophylline therapy .

结论：长期应用β2受体激动剂会导致β受体下调，长期应用溴化异丙托品和茶碱对β受体无影响。

Objective : To compare the effect of ipratropium bromide ( IPB ) with sulbutamol ( SA ), on bronchodilatation in patients with asthma and COPD .

目的：比较溴化异丙托品（IPB）气雾剂与沙丁胺醇（SA）气雾剂分别使用及联合应用对哮喘和COPD患者的支扩作用。

0.25 ~ 1.0 mL of salbutamol or ipratropium bromide was diluted to 2 mL with 0.9 % sodium chloride solution for nebulization , 2 ~ 4 times a day .

沙丁胺醇雾化液与异丙托溴铵雾化液（用量均为0.25～1.00mL）用0.9%氯化钠溶液稀释至2mL，雾化吸入，每日2～4次。

Objective To compare the effects of varying doses of inhaled ipratropium bromide ( TPB ) and the impact on lung function and exercise tolerance using progressive cycle ergometry in patients with stable COPD .

目的观察不同剂量的溴化异丙托品（IPB）短时及长期应用，对稳定期慢性阻塞性肺疾病（COPD）患者的肺功能及运动耐受性的影响。

Conclusion : Treatment of infantile asthmatoid bronchitis with aerosol inhalation of salbutamol and ipratropium bromide was found to relieve symptoms shorten the course of the disease , and improve the prognosis .

结论：沙丁胺醇加异丙托溴铵雾化吸入治疗婴幼儿喘息性支气管炎能减轻症状，缩短病程，改善预后。

Conclusions : These bronchodilator agents routinely used can improve the symptom of dyspnea in severe COPD patients at stable stage , but the effects of combined administration of fenoterol and ipratropium bromide are obviously more satisfactory .

结论：对重度COPD稳定期患者在常规治疗下雾化吸入支气管扩张剂能改善其临床气促症状，而联合应用非诺特罗和异丙托溴铵疗效优于任何一药单独应用。

Method : 40 stable asthma patients and 10 health volunteers were involved into our study . The asthma patients were treated with ipratropium bromide ,β 2 agonist , ipratropium bromide and agonist , and theophylline randomly .

方法：选取稳定期哮喘患者和健康志愿者为研究对象，对哮喘患者分别应用溴化异丙托品、β2受体激动剂、联合应用溴化异丙托品和β2受体激动剂、茶碱。